Research Paper Volume 13, Issue 14 pp 18806—18826
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
Figure 2. Comparison with other prognostic biomarkers and validation of eight-IRlncRNA signature in the validation cohort (PACA-CA). (A) ROC curve of eight-IRlncRNA signature for 1, 3, 5- year survival. (B) Kaplan-Meier curves for the high- and low-risk groups. (C) Risk score distribution and the survival status for patients. (D) Time-dependent ROC curve for the eight-IRlncRNA signature compared with other prognosis biomarkers.